Hypothesis and Theory
Published on 05 Aug 2020
DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19—A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01185
- 6,449 views
- 27 citations
